29 results on '"Schönland, Stefan"'
Search Results
2. Response to therapy with tafamidis 61 mg in patients with cardiac transthyretin amyloidosis: real-world experience since approval.
3. Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.
4. Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study
5. Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group
6. Identification of AL proteins from 10 λ-AL amyloidosis patients by mass spectrometry extracted from abdominal fat and heart tissue
7. Lysozyme amyloidosis—a report on a large German cohort and the characterisation of a novel amyloidogenic lysozyme gene variant
8. Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group.
9. Identification of AL proteins from 10 λ-AL amyloidosis patients by mass spectrometry extracted from abdominal fat and heart tissue.
10. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres
11. Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies
12. Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis
13. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience
14. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres.
15. Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients
16. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
17. New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusing
18. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis
19. Diagnostic work up of an adult female patient with systemic AA amyloidosis revealing the cause of infantile mental retardation
20. Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis
21. Amyloid in bone marrow smears in systemic light-chain amyloidosis
22. Risk factors for AA amyloidosis in Germany
23. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis
24. Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone
25. Doxycycline in ATTRY69H (p.ATTRY89H) amyloidosis with predominant leptomeningeal manifestation
26. Cerebral amyloid angiopathy – an underdiagnosed entity in younger adults with lobar intracerebral hemorrhage?
27. Risk factors for AA amyloidosis in Germany.
28. Cerebral amyloid angiopathy - an underdiagnosed entity in younger adults with lobar intracerebral hemorrhage?
29. Diagnostic work up of an adult female patient with systemic AA amyloidosis revealing the cause of infantile mental retardation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.